Dyadic International Inc.
News
Dyadic International Second Quarter 2024 Earnings: Misses Expectations
Simply Wall St Dyadic International ( NASDAQ:DYAI ) Second Quarter 2024 Results Key Financial Results Revenue: US$385.9k (down 54...\n more…
Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript
Seeking Alpha: Transcripts Dyadic International, Inc. (DYAI) Q2 2024 Earnings Call Transcript...\n more…
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nDYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the second...\n more…
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Globe Newswire Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and BiologicalsEntered into a joint...\n more…
Reviewing Dyadic International (NASDAQ:DYAI) & Athira Pharma (NASDAQ:ATHA)
Ticker Report Dyadic International (NASDAQ:DYAI - Get Free Report) and Athira Pharma (NASDAQ:ATHA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the...\n more…